Overview

Initial Combination With Pioglitazone Study (0431-064)

Status:
Completed
Trial end date:
2008-06-28
Target enrollment:
Participant gender:
Summary
A clinical study to evaluate the safety and efficacy of the initial combination therapy with sitagliptin and pioglitazone in patients with type 2 diabetes mellitus not on treatment with insulin or oral antihyperglycemic therapy.
Phase:
Phase 3
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Pioglitazone
Sitagliptin Phosphate